Tesis sobre el tema "BRCA testing"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 23 mejores tesis para su investigación sobre el tema "BRCA testing".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore tesis sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Pack, Jessica K. B. A. "The Impact of the Myriad Direct-to-Consumer Advertising Campaign for BRCA1/2 Genetic Testing in the Greater Cincinnati Area". University of Cincinnati / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1311692006.
Texto completoFerlatte, Christy. "Patient preferences for an appropriate time for cancer genetic counseling and BRCA testing for women diagnosed with breast cancer". Waltham, Mass. : Brandeis University, 2009. http://dcoll.brandeis.edu/handle/10192/23193.
Texto completoChristopher, Juleen L. "An Examination of Dimensions of Perceived Behavioral Control Regarding Genetic Counseling and Testing for BRCA 1 and BRCA 2 in African-American Women at Moderate to High-Risk for Breast Cancer". Diss., Virginia Tech, 2010. http://hdl.handle.net/10919/77364.
Texto completoPh. D.
Chadwell, Sarah E. B. S. "Factors Influencing Clinical Follow-up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Negative or Uncertain BRCA1 and BRCA2 Testing". University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491317215551797.
Texto completoElliott, Diana. "The impact of genetic counselling for familial breast cancer on women's psychological distress, risk perception and understanding of BRCA testing". University of Western Australia. School of Population Health, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0190.
Texto completoArver, Brita. "Hereditary breast/ovarian cancer : implementation of BRCA1 & BRCA2 testing /". Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4799-6/.
Texto completoKeenan, Lisa A. "Family Environment, Social Support, and Psychological Distress of Women Seeking BRCA1 and BRCA2 Genetic Mutation Testing". Thesis, University of North Texas, 2002. https://digital.library.unt.edu/ark:/67531/metadc3240/.
Texto completoDoughty, Courtney R. "Retrospective Comparison of In-person versus Telephone Results Disclosure Counseling for BRCA1/2 Genetic Testing". University of Cincinnati / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1211940755.
Texto completoLesniak, Karen. "Psychological and Sociodemographic Predictors of Psychological Distress in BRCA1 and BRCA2 Genetic Testing Participants within a Community Based Genetic Screening Program". Thesis, University of North Texas, 2000. https://digital.library.unt.edu/ark:/67531/metadc2565/.
Texto completoColtri, Julia Anne. "Transgender male patients and hereditary breast cancer risk: broaching difficult topics to reduce healthcare disparities". The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1555683611281611.
Texto completoBajdik, Christopher Douglas. "Family history of breast/ovarian cancer and referral criteria for a BRCA1 testing program". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/NQ61058.pdf.
Texto completoSuzuki, Ayaka. "Familial Communication of Positive BRCA1/2 Genetic Testing Results: A Relational Dialectics Theory Approach". University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1504787059498275.
Texto completoChivers, Seymour Kimberley-Clair. "Talking to relatives about genetic testing for BRCA1/2 and its risk implications : an on-going discussion". Thesis, University of Southampton, 2013. https://eprints.soton.ac.uk/354118/.
Texto completoVan, Tassel William Edward. "An evaluation of pocket-model, numerical readout breath alcohol testing instruments". Texas A&M University, 2003. http://hdl.handle.net/1969.1/1159.
Texto completoSkates, Steven J., Mark H. Greene, Saundra S. Buys, Phuong L. Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez et al. "Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk-combined results from two screening trials". American Association for Cancer Research, 2017. http://hdl.handle.net/10150/625973.
Texto completoHolmes, Christina Patrice. "You're armed, I think you're better armed, women's opinions of genetic counselling and testing for hereditary breast and ovarian cancer susceptibility (BRCA1)". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0009/MQ52793.pdf.
Texto completoGibbons, Deborah Kay. "“It's Not Only About Them:“ Female Family Members' Understanding of Indeterminate Negative BRCA1/2 Test Results". BYU ScholarsArchive, 2018. https://scholarsarchive.byu.edu/etd/7701.
Texto completoWilliams-Jones, Bryn. "Genetic testing for sale : implications of commercial BRCA testing in Canada". Thesis, 2002. http://hdl.handle.net/2429/13580.
Texto completoMaheu, Christine. "Interpreting and making sense of uninformative results of testing for BRCA 1 and BRCA 2 cancer gene mutations". Thesis, 2005. http://hdl.handle.net/2429/17030.
Texto completoApplied Science, Faculty of
Nursing, School of
Graduate
Ozakinci, Gozde. "Psychological and behavioral outcomes of genetic testing for BRCA1/2 mutations among Ashkenazi Jewish Women /". 2004. http://wwwlib.umi.com/dissertations/fullcit/3153612.
Texto completoMoura, Ana Luísa Pinto da Silva Lobo Peixoto de. "Spectrum of BRCA1 and BRCA2 germline mutations in Portuguese Hereditary Breast and Ovarian cancer: ancestral origin of founder mutations and their implications for genetic testing criteria and strategy". Tese, 2019. https://hdl.handle.net/10216/122595.
Texto completoMoura, Ana Luísa Pinto da Silva Lobo Peixoto de. "Spectrum of BRCA1 and BRCA2 germline mutations in Portuguese Hereditary Breast and Ovarian cancer: ancestral origin of founder mutations and their implications for genetic testing criteria and strategy". Doctoral thesis, 2019. https://hdl.handle.net/10216/122595.
Texto completoMagro, Tatiana Natália Tavares. "Testing the combinatory use of PARP1 and RPA inhibitors in breast cancer cell lines". Master's thesis, 2019. http://hdl.handle.net/10773/29527.
Texto completoA perda do supressor tumoral BRCA2 está fortemente associada ao cancro da mama. O BRCA2 é essencial para a recombinação homóloga, que é uma via de reparação de ADN crucial para a estabilidade genómica. Quando as células sofrem mutações neste gene, elas não conseguem reparar os danos no ADN através da recombinação homóloga, que é uma via de reparação precisa, e em vez disso, tornam-se dependentes de vias alternativas, propensas a erros, para reparação de ADN. Deste modo, as células tumorais mutantes para BRCA2 tornam-se dependentes destas vias alternativas para sobreviverem. A geração mais recente de terapias direcionadas são os inibidores da PARP1. A PARP1 é uma proteína essencial para a iniciação de várias vias de reparação de ADN, incluindo as tais vias de reparação alternativas, como a non-homologous end joining (NHEJ). A utilização destes inibidores compromete as vias alternativas levando à morte das células tumorais. Embora as células tumorais mutantes para BRCA2 sejam particularmente sensíveis aos inibidores da PARP1, o aparecimento da resistência tumoral tem sido observado frequentemente após tratamentos de longo-prazo. Este problema motivou-nos a procurar proteínas alternativas cuja inibição prejudicasse especificamente, à semelhança da PARP1, a viabilidade e/ou crescimento das células tumorais. Foi recentemente reportado que o BRCA2 regula a transcrição da ARN polimerase II e previne a formação de R-loops, que são estruturas de ácidos nucleicos de 3 cadeias compostas por híbridos de ADN:ARN. A acumulação destes R-loops está implicada no processo de carcinogénese devido à acumulação de ADN de cadeia simples (do inglês ssDNA) e ao aumento de instabilidade genómica. O RPA é uma proteína que se liga ao ssDNA e evita que se formem estruturas secundárias, sendo crucial para a replicação e reparação de ADN. O nosso objetivo é identificar novos alvos terapêuticos cuja inibição possa ser usada em combinação ou como alternativa aos inibidores da PARP1, minimizando o risco de resistência tumoral. A nossa hipótese de trabalho é que a inibição combinatória de PARP1 e RPA aumentará especificamente a perda de viabilidade das células de cancro da mama.
Mestrado em Biomedicina Molecular